These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24045028)

  • 1. "It's effective therapy, stupid!".
    Ravandi F
    Leuk Res; 2013 Nov; 37(11):1434-5. PubMed ID: 24045028
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
    Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
    Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Cervera J; Montesinos P; Hernández-Rivas JM; Calasanz MJ; Aventín A; Ferro MT; Luño E; Sánchez J; Vellenga E; Rayón C; Milone G; de la Serna J; Rivas C; González JD; Tormo M; Amutio E; González M; Brunet S; Lowenberg B; Sanz MA
    Haematologica; 2010 Mar; 95(3):424-31. PubMed ID: 19903674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute promyelocytic leukemia with t(15;17) and two previously unreported additional cytogenetic abnormalities.
    Rashidi A; Fisher SI
    Med Oncol; 2013 Mar; 30(1):392. PubMed ID: 23275121
    [No Abstract]   [Full Text] [Related]  

  • 5. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
    Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
    Zuberi L; Adeyinka A; Kuriakose P
    Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
    [No Abstract]   [Full Text] [Related]  

  • 7. Current treatment of acute promyelocytic leukemia.
    Lo Coco F; Ammatuna E; Sanz MA
    Haematologica; 2007 Mar; 92(3):289-91. PubMed ID: 17339175
    [No Abstract]   [Full Text] [Related]  

  • 8. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
    Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
    Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Iaccarino L; Ottone T; Hasan SK; Divona M; Cicconi L; Lavorgna S; Alfonso V; Basso G; Barragán E; Bocchia M; Rego EM; Grimwade D; Voso MT; Lo-Coco F
    Leuk Lymphoma; 2018 May; 59(5):1268-1270. PubMed ID: 28838264
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous infiltration in acute promyelocytic leukemia.
    Ueda K; Kume A; Furukawa Y; Higashi N
    J Am Acad Dermatol; 1997 Jan; 36(1):104-6. PubMed ID: 8996272
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
    Gutiérrez de Guzmán J; Kantarjian H
    Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to therapy in acute promyelocytic leukemia.
    Lehmann-Che J; Bally C; de Thé H
    N Engl J Med; 2014 Sep; 371(12):1170-2. PubMed ID: 25229938
    [No Abstract]   [Full Text] [Related]  

  • 14. PHA-Induced Peripheral Blood Cytogenetics and Molecular Analysis: a Valid Diagnostic and Follow-up Modality for Acute Promyelocytic Leukemia Patients Treated with ATRA and/or Arsenic Tri-oxide.
    Baba SM; Azad NA; Shah ZA; Afroze D; Pandith AA; Jan A; Aziz SA; Dar FA
    Asian Pac J Cancer Prev; 2016; 17(4):1999-2006. PubMed ID: 27221887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extramedullary relapse confirmed by fluorescence in situ hybridization study of an ear mass in acute promyelocytic leukemia.
    Lee KW; Yi J; Yun T; Kim DY; Lee DS; Park SS; Cho HI; Yoon SS; Park S; Kim BK; Kim NK
    Int J Hematol; 2004 Jun; 79(5):462-4. PubMed ID: 15239396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term molecular remission in promyelocytic transformation of myeloproliferative disease.
    Mollee PN; Taylor KM; Williams B; Taylor D; Rodwell R
    Leukemia; 1999 Apr; 13(4):648-50. PubMed ID: 10214878
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U; Lo-Coco F
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial.
    Diverio D; Rossi V; Avvisati G; De Santis S; Pistilli A; Pane F; Saglio G; Martinelli G; Petti MC; Santoro A; Pelicci PG; Mandelli F; Biondi A; Lo Coco F
    Blood; 1998 Aug; 92(3):784-9. PubMed ID: 9680345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of acute promyelocytic leukemia with the STAT5B-RARA fusion gene.
    Zhang C; Wang Y; Liu B; Gong B; Gong X; Liu Y; Mi Y; Wang J
    Blood Cells Mol Dis; 2018 Mar; 69():71-73. PubMed ID: 29030091
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Labrador J; Luño E; Vellenga E; Brunet S; González-Campos J; Chillón MC; Holowiecka A; Esteve J; Bergua J; González-Sanmiguel JD; Gil C; Tormo M; Salamero O; Manso F; Fernández I; de laSerna J; Moreno MJ; Pérez-Encinas M; Krsnik I; Ribera JM; Cervera J; Calasanz MJ; Boluda B; Sobas M; Lowenberg B; Sanz MA; Montesinos P
    Leuk Lymphoma; 2019 May; 60(5):1146-1155. PubMed ID: 30526152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.